Hhlr Advisors, Ltd. Tango Therapeutics, Inc. Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.86 - $8.01 $3.4 Million - $7.07 Million	-882,088 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.01 - $10.94 $21 Million - $32.7 Million	-2,991,894 Reduced 77.23%	882,088 $6.69 Million
Q4 2021 Feb 14, 2022	SELL	$9.55 - $14.29 $4.78 Million - $7.15 Million	-500,000 Reduced 11.43%	3,873,982 $42.4 Million
Q3 2021 Nov 15, 2021	BUY	$9.56 - $17.3 $41.8 Million - $75.7 Million	4,373,982 New	4,373,982 $56.6 Million

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $359M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.